Yaz® and Yasmin® Birth Control Pills Linked to 23 Deaths in Canada
According to a recent report, Health Canada has received reports of 23 young Canadian women who died while using either Yaz® or Yasmin®, which are combination oral contraceptives. Over half of the reported deaths involved women under the age of 26 and as young as age 14. Most of the deaths occurred shortly after the women began taking these birth control pills and involved such injuries as pulmonary embolism (blood clots that travel to the lungs) or cerebral thrombosis (blood clots in the brain). A Health Canada review reveals that women taking Yasmin® and Yaz® are 1.5 to 3 times more likely to suffer a blood clot than women on other combination oral contraceptives. Nevertheless, Yaz® and Yasmin® remain available on the Canadian market.
Women in the United States have suffered similar injuries as a result of Yaz® and Yasmin® and have filed claims against the manufacturers. These lawsuits have been consolidated into a Multi-District Litigation (MDL No. 2100) pending in the United States District Court for the Southern District of Illinois. Schlichter, Bogard & Denton represents numerous clients across the nation and is at the forefront of this litigation. Schlichter, Bogard & Denton founding partner, Roger C. Denton [hyperlink], was appointed by The Honorable Judge David R. Herndon to serve as Liaison Counsel over the MDL. If you or a loved one have suffered injuries as a result of Yaz® or Yasmin®, please contact us at 1-800-873-5297 for a free consultation.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.